Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Travis J. Friesen"'
Autor:
Huajia Zhang, Xiaodong Zhu, Travis J. Friesen, Jeff W. Kwak, Tatyana Pisarenko, Surapat Mekvanich, Mark A. Velasco, Timothy W. Randolph, Julia Kargl, A. McGarry Houghton
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 22 (2022)
Myeloid lineage cells suppress T cell viability through arginine depletion via arginase 1 (ARG1). Despite numerous studies exploring the mechanisms by which ARG1 perturbs lymphocyte function, the cellular populations responsible for its generation an
Externí odkaz:
https://doaj.org/article/ea22b9ea0f034276943aff6b41b27330
Autor:
Joseph B. Hiatt, Holly Sandborg, Sarah M. Garrison, Henry U. Arnold, Sheng-You Liao, Justin P. Norton, Travis J. Friesen, Feinan Wu, Kate D. Sutherland, Hugh Y. Rienhoff, Renato Martins, A. McGarry Houghton, Shivani Srivastava, David MacPherson
Publikováno v:
Clin Cancer Res
Purpose: The addition of immune checkpoint blockade (ICB) to platinum/etoposide chemotherapy changed the standard of care for small cell lung cancer (SCLC) treatment. However, ICB addition only modestly improved clinical outcomes, likely reflecting t
Autor:
David MacPherson, Shivani Srivastava, A. McGarry Houghton, Renato Martins, Hugh Y. Rienhoff, Kate D. Sutherland, Feinan Wu, Travis J. Friesen, Justin P. Norton, Sheng-You Liao, Henry U. Arnold, Sarah M. Garrison, Holly Sandborg, Joseph B. Hiatt
Purpose:The addition of immune checkpoint blockade (ICB) to platinum/etoposide chemotherapy changed the standard of care for small cell lung cancer (SCLC) treatment. However, ICB addition only modestly improved clinical outcomes, likely reflecting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d029b71b7ed5b054576af608f27cdf
https://doi.org/10.1158/1078-0432.c.6532733.v1
https://doi.org/10.1158/1078-0432.c.6532733.v1
Autor:
David MacPherson, Shivani Srivastava, A. McGarry Houghton, Renato Martins, Hugh Y. Rienhoff, Kate D. Sutherland, Feinan Wu, Travis J. Friesen, Justin P. Norton, Sheng-You Liao, Henry U. Arnold, Sarah M. Garrison, Holly Sandborg, Joseph B. Hiatt
Supplementary Figure from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0598cb709fc1b05db39745388fe770f9
https://doi.org/10.1158/1078-0432.22488479
https://doi.org/10.1158/1078-0432.22488479
Autor:
A. McGarry Houghton, Melissa Shipley, Jill McKay-Fleisch, Afshin Mashadi-Hossein, Gavin Meredith, Julia Kargl, John A. Zebala, Robert H. Pierce, Grace H. Y. Yang, Jeffrey C. Thompson, Dean Y. Maeda, Huajia Zhang, Steven M. Albelda, Xiaodong Zhu, Christina S. Baik, Hamid Bolouri, Mary W. Redman, Travis J. Friesen
Publikováno v:
JCI insight. 4(24)
Immune checkpoint inhibitor (ICI) treatment has recently become a first-line therapy for many non–small cell lung cancer (NSCLC) patients. Unfortunately, most NSCLC patients are refractory to ICI monotherapy, and initial attempts to address this is
Autor:
Nikole Perdue, Ken Coppieters, Anna K E Rydén, Tamar E. Boursalian, Philippe P. Pagni, Travis J. Friesen, Sowbarnika S. Ratliff, Claire B. Gibson, Claus Haase, Rikke Kaae Kirk, Matthias von Herrath
Publikováno v:
Journal of autoimmunity. 84
Immunotherapy for type 1 diabetes (T1D) has previously focused on suppressing the autoimmune response against pancreatic beta cells to preserve endogenous insulin production and regulate glucose levels. With increased attention toward combination the